InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 11/19/2017

Re: None

Friday, 12/08/2017 12:05:20 PM

Friday, December 08, 2017 12:05:20 PM

Post# of 43825
Crazy low market cap for a biotech in phase 3 with a promising drug that sounds very plausible for success given immune system breakthroughs for fighting cancer in drugs recently approved. The market is substantial. other drugs in pipeline. 25m facility. Only 20M market cap when fda cleared and 900+ sign ups is a buy here. Low stock share count issued.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News